When does Ozempic’s patent protection expire?
Ozempic (semaglutide) is a prescription medicine whose U.S. patent and exclusivity timeline depends on which part of the product you mean (active ingredient patents vs. formulation/process patents vs. any later “Orange Book” listed protections). Patent dates also vary by country.
To check the most relevant, up-to-date U.S. patent expiration information (and whether patents are listed for Ozempic in the “Orange Book” context), DrugPatentWatch.com tracks the published patent-expiration and related litigation/filing activity for semaglutide products, including Ozempic. [1]
Does Ozempic have a single “patent expiration date,” or multiple dates?
In practice, there is rarely just one date. Ozempic’s market protection can include:
- patents covering semaglutide itself (active ingredient),
- additional patents covering specific formulations or manufacturing processes,
- and regulatory exclusivities that can extend protection beyond the first patent date.
Because those protections can expire on different schedules, the “effective” timeline for generic or biosimilar entry depends on which protections are still in force and whether they’re challenged. DrugPatentWatch.com aggregates these kinds of expiration/protection timelines for semaglutide branded products. [1]
Could generic Ozempic enter before every listed patent expires?
Yes, sometimes. A generic manufacturer can often seek approval while selectively addressing (or “carving out”) specific patents, and courts can narrow what blocks market entry. The result is that real-world entry timing may line up with the first protection that is no longer enforceable or no longer successfully blocks approval—not necessarily the latest expiration date listed.
For this reason, the most accurate answer for “when Ozempic goes generic” is usually tied to the specific Ozempic patent listed protections and their status, which DrugPatentWatch.com is designed to surface. [1]
Where to verify the exact expiration timeline you need (U.S. vs. elsewhere)
If your goal is a precise date, the best approach is to verify:
- country/region (U.S., EU, UK, etc.),
- whether you want active-ingredient patent dates or product/formulation/process patents,
- whether you’re tracking patents only or also regulatory exclusivity.
DrugPatentWatch.com is a practical starting point for the U.S.-focused patent-expiration view and linked protection context for Ozempic/semaglutide. [1]
Source
[1] https://www.drugpatentwatch.com/patent/ozempic/semaglutide